Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000200224> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2000200224 endingPage "3539" @default.
- W2000200224 startingPage "3539" @default.
- W2000200224 abstract "Abstract In cancer, increased infiltration of macrophages within and surrounding the tumor mass correlates with increased tumor invasiveness and growth. In addition, presence of tumor-associated macrophages (TAMs) has been shown to correlate with poor prognosis, particularly in breast, prostate, ovarian and cervical cancer. TAM proliferation, differentiation and survival is dependent on Colony Stimulating Factor - 1 Receptor (CSF-1R) activation, a type III integral membrane tyrosine kinase receptor selectively expressed on cells of the mononuclear phagocyte lineage. Given that TAMs enhance tumor growth and that activation of the CSF-1R pathway is required for TAM function, an antibody against mouse CSF-1R was generated for proof-of-principle studies. CS7, a monoclonal anti-mouse CSF-1R antibody inhibited both CSF-1 and IL-34 binding to mouse CSF-1R, leading to inactivation of the receptor and downstream signaling molecules. In addition, CS7 prevented monocyte proliferation and macrophage differentiation with IC50s of 0.1 nM and 0.75 nM, respectively. In murine models of breast cancer using CSF-1-secreting MDA-MB-231, Hcc1954, 4T1 or EMT6 tumor cells, CS7 treatment led to a marked reduction in TAMs and an associated decrease in tumor growth. In contrast, breast tumor xenografts with CSF-1 non-secreting breast tumor cell lines JimT1 and MCF-7 had limited or no decrease in tumor volume following CS7 treatment. In prostate models, DU145 tumor cell line xenografts (CSF-1-secreting) but not PC3 (CSF-1 non-secreting) tumor growth was inhibited by CS7, recaptitulating the results seen with breast xenografts. Thus, in breast and prostate preclinical models, CSF-1 secretion by tumor cells is a prerequisite for sensitivity to anti-CSF-1R treatment. Taken together, targeting CSF-1R with a monoclonal antibody inhibits CSF-1R signaling via CSF-1 and IL-34, prevents monocytic to macrophage differentiation, and reduces tumor volume in preclinical models, validating CSF-1R as a target for therapeutic application in cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 3539. doi:1538-7445.AM2012-3539" @default.
- W2000200224 created "2016-06-24" @default.
- W2000200224 creator A5003707177 @default.
- W2000200224 creator A5017195993 @default.
- W2000200224 creator A5026263385 @default.
- W2000200224 creator A5028038353 @default.
- W2000200224 creator A5028710666 @default.
- W2000200224 creator A5046226560 @default.
- W2000200224 creator A5067350056 @default.
- W2000200224 creator A5071983100 @default.
- W2000200224 creator A5079048970 @default.
- W2000200224 creator A5080769460 @default.
- W2000200224 creator A5088020494 @default.
- W2000200224 date "2012-04-01" @default.
- W2000200224 modified "2023-09-26" @default.
- W2000200224 title "Abstract 3539: Anti-CSF-1R antibodies reduce tumor-associated macrophages and inhibit tumor growth in preclinical models" @default.
- W2000200224 doi "https://doi.org/10.1158/1538-7445.am2012-3539" @default.
- W2000200224 hasPublicationYear "2012" @default.
- W2000200224 type Work @default.
- W2000200224 sameAs 2000200224 @default.
- W2000200224 citedByCount "1" @default.
- W2000200224 countsByYear W20002002242021 @default.
- W2000200224 crossrefType "journal-article" @default.
- W2000200224 hasAuthorship W2000200224A5003707177 @default.
- W2000200224 hasAuthorship W2000200224A5017195993 @default.
- W2000200224 hasAuthorship W2000200224A5026263385 @default.
- W2000200224 hasAuthorship W2000200224A5028038353 @default.
- W2000200224 hasAuthorship W2000200224A5028710666 @default.
- W2000200224 hasAuthorship W2000200224A5046226560 @default.
- W2000200224 hasAuthorship W2000200224A5067350056 @default.
- W2000200224 hasAuthorship W2000200224A5071983100 @default.
- W2000200224 hasAuthorship W2000200224A5079048970 @default.
- W2000200224 hasAuthorship W2000200224A5080769460 @default.
- W2000200224 hasAuthorship W2000200224A5088020494 @default.
- W2000200224 hasConcept C121608353 @default.
- W2000200224 hasConcept C126322002 @default.
- W2000200224 hasConcept C202751555 @default.
- W2000200224 hasConcept C2776438761 @default.
- W2000200224 hasConcept C2779244956 @default.
- W2000200224 hasConcept C2779723316 @default.
- W2000200224 hasConcept C2780192828 @default.
- W2000200224 hasConcept C502942594 @default.
- W2000200224 hasConcept C50442881 @default.
- W2000200224 hasConcept C55493867 @default.
- W2000200224 hasConcept C71924100 @default.
- W2000200224 hasConcept C86803240 @default.
- W2000200224 hasConceptScore W2000200224C121608353 @default.
- W2000200224 hasConceptScore W2000200224C126322002 @default.
- W2000200224 hasConceptScore W2000200224C202751555 @default.
- W2000200224 hasConceptScore W2000200224C2776438761 @default.
- W2000200224 hasConceptScore W2000200224C2779244956 @default.
- W2000200224 hasConceptScore W2000200224C2779723316 @default.
- W2000200224 hasConceptScore W2000200224C2780192828 @default.
- W2000200224 hasConceptScore W2000200224C502942594 @default.
- W2000200224 hasConceptScore W2000200224C50442881 @default.
- W2000200224 hasConceptScore W2000200224C55493867 @default.
- W2000200224 hasConceptScore W2000200224C71924100 @default.
- W2000200224 hasConceptScore W2000200224C86803240 @default.
- W2000200224 hasIssue "8_Supplement" @default.
- W2000200224 hasLocation W20002002241 @default.
- W2000200224 hasOpenAccess W2000200224 @default.
- W2000200224 hasPrimaryLocation W20002002241 @default.
- W2000200224 hasRelatedWork W2062196172 @default.
- W2000200224 hasRelatedWork W2118642421 @default.
- W2000200224 hasRelatedWork W2165750431 @default.
- W2000200224 hasRelatedWork W2342747098 @default.
- W2000200224 hasRelatedWork W2593394863 @default.
- W2000200224 hasRelatedWork W2728077352 @default.
- W2000200224 hasRelatedWork W3126290430 @default.
- W2000200224 hasRelatedWork W3160990505 @default.
- W2000200224 hasRelatedWork W3179568116 @default.
- W2000200224 hasRelatedWork W4361813216 @default.
- W2000200224 hasVolume "72" @default.
- W2000200224 isParatext "false" @default.
- W2000200224 isRetracted "false" @default.
- W2000200224 magId "2000200224" @default.
- W2000200224 workType "article" @default.